JPS6442433A - Fine particle containing biodegradable polymer for controlling release of antimalarial effective component, medicinal composition and manufacture - Google Patents

Fine particle containing biodegradable polymer for controlling release of antimalarial effective component, medicinal composition and manufacture

Info

Publication number
JPS6442433A
JPS6442433A JP63188520A JP18852088A JPS6442433A JP S6442433 A JPS6442433 A JP S6442433A JP 63188520 A JP63188520 A JP 63188520A JP 18852088 A JP18852088 A JP 18852088A JP S6442433 A JPS6442433 A JP S6442433A
Authority
JP
Japan
Prior art keywords
active ingredient
fine particle
medicinal composition
biodegradable polymer
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63188520A
Other languages
English (en)
Inventor
Bonten Jiyoze
Piruson Fuiritsupu
Fuarumaajiyu Jiyannberunaaru
Jiyoromu Roberuto
Teishii Fuiritsupu
Deratoure Riyuku
Eburarudo Burijitsuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
II R EE SERUTAARUKU SA
Original Assignee
II R EE SERUTAARUKU SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by II R EE SERUTAARUKU SA filed Critical II R EE SERUTAARUKU SA
Publication of JPS6442433A publication Critical patent/JPS6442433A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP63188520A 1987-07-30 1988-07-29 Fine particle containing biodegradable polymer for controlling release of antimalarial effective component, medicinal composition and manufacture Pending JPS6442433A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8710802A FR2618674B1 (fr) 1987-07-30 1987-07-30 Microparticules comportant un polymere biodegradable controlant la liberation d'un principe actif antimalarique, compositions pharmaceutiques en comprenant et procede de preparation

Publications (1)

Publication Number Publication Date
JPS6442433A true JPS6442433A (en) 1989-02-14

Family

ID=9353715

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63188520A Pending JPS6442433A (en) 1987-07-30 1988-07-29 Fine particle containing biodegradable polymer for controlling release of antimalarial effective component, medicinal composition and manufacture

Country Status (9)

Country Link
US (1) US4897267A (ja)
EP (1) EP0301969B1 (ja)
JP (1) JPS6442433A (ja)
AT (1) ATE66372T1 (ja)
CA (1) CA1329549C (ja)
DE (1) DE3864348D1 (ja)
ES (1) ES2024668B3 (ja)
FR (1) FR2618674B1 (ja)
GR (1) GR3002601T3 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2644462B1 (fr) * 1988-09-23 1993-07-09 Ire Celltarg Sa Nouveaux composes actifs sur les formes tissulaires de la malaria et procede de preparation
LU87410A1 (fr) * 1988-12-20 1990-07-10 Cird Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
FR2659554B1 (fr) 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
US5766635A (en) * 1991-06-28 1998-06-16 Rhone-Poulenc Rorer S.A. Process for preparing nanoparticles
US5610753A (en) * 1991-12-12 1997-03-11 Eastman Kodak Company Optical design of laser scanner to reduce thermal sensitivity
ZA93929B (en) * 1992-02-18 1993-09-10 Akzo Nv A process for the preparation of biologically active materialcontaining polymeric microcapsules.
US6689608B1 (en) 1993-02-01 2004-02-10 Massachusetts Institute Of Technology Porous biodegradable polymeric materials for cell transplantation
US5514378A (en) * 1993-02-01 1996-05-07 Massachusetts Institute Of Technology Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5569468A (en) * 1994-02-17 1996-10-29 Modi; Pankaj Vaccine delivery system for immunization, using biodegradable polymer microspheres
US5417982A (en) * 1994-02-17 1995-05-23 Modi; Pankaj Controlled release of drugs or hormones in biodegradable polymer microspheres
US5626862A (en) 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
FR2764514B1 (fr) 1997-06-13 1999-09-03 Biopharmex Holding Sa Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
US6306425B1 (en) 1999-04-09 2001-10-23 Southern Research Institute Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
ATE280579T1 (de) 1999-08-27 2004-11-15 Southern Res Inst Injizierbare buprenorphinhaltige mikrosphärenzusammensetzungen und ihre verwendung zur reduktion von heroin- und alkoholkonsum
CN1194704C (zh) * 2001-11-12 2005-03-30 华东理工大学 含有活性药物、主链中具有氨基酸的聚酯及其制备方法
DK1722761T3 (da) * 2004-01-21 2011-03-28 Univ London Pharmacy Fremgangsmåde til frembringelse af mikropartikler

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL263733A (ja) * 1960-04-19 1900-01-01
BE755975A (fr) * 1969-09-10 1971-03-10 Dann Otto Nouveaux derives de la quinoleine, compositions pharmaceutiquesen contenant et leur obtention
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3663552A (en) * 1970-04-09 1972-05-16 American Home Prod 2'-substituted-cinchona alkaloids
DE2748333A1 (de) * 1977-10-28 1979-05-03 Hoechst Ag Mittel gegen malaria
US4416872A (en) * 1982-03-17 1983-11-22 The United States Of America As Represented By The Secretary Of The Army Treatment of malaria with liposomes containing 8-aminoquinoline derivatives and glycoconjugates
CA1196864A (en) * 1983-06-10 1985-11-19 Mattheus F.A. Goosen Controlled release of injectable and implantable insulin compositions

Also Published As

Publication number Publication date
FR2618674A1 (fr) 1989-02-03
US4897267A (en) 1990-01-30
EP0301969B1 (fr) 1991-08-21
GR3002601T3 (en) 1993-01-25
FR2618674B1 (fr) 1990-06-15
EP0301969A1 (fr) 1989-02-01
ATE66372T1 (de) 1991-09-15
CA1329549C (fr) 1994-05-17
ES2024668B3 (es) 1992-03-01
DE3864348D1 (de) 1991-09-26

Similar Documents

Publication Publication Date Title
JPS6442433A (en) Fine particle containing biodegradable polymer for controlling release of antimalarial effective component, medicinal composition and manufacture
UA27707C2 (uk) Фармацевтичний препарат подовженої дії, полімерна основа, яка призначена для використання в фармацевтичних препаратах подовженої дії, та спосіб її одержання
TW333456B (en) A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
SE8803321D0 (sv) Fordrojd och styrd frigoring av vattenolosliga polypeptider
IL111647A0 (en) Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them
GR3021627T3 (en) Pharmaceutical formulations of osteogenic proteins
KR890003400A (ko) 경비(經鼻)투여용 생리 활성 펩티드 분말 조성물(제제)
AU6819294A (en) Oral drug delivery compositions and methods
RU94022269A (ru) Состав аэрозоля, находящийся под давлением
IL102591A (en) Compositions for the sustained and controlled release of peptide medicaments and their preparation
EP1072255B8 (en) Oral delivery system for desferrioxamine, insulin and cromolyn sodium
HUT70211A (en) Proteinoid carriers and methods for preparation and use thereof
ES2001512A6 (es) Procedimiento para la fabricacion de esteres totales y parciales del acido hialuronico
CA2135062A1 (en) Pharmaceutical and Other Dosage Forms
HUT59940A (en) Process for producing decapeptides antagonizing releasing hormone of lutheinizing hormone and pharmaceutical compositions containing them as active components
WO1993025191A3 (fr) Microspheres en polymere bioresorbable, exemptes de tensioactif, leur preparation et leur application comme medicament
EP0113505A1 (en) Water-soluble polyesters
IL79816A0 (en) Pharmaceutical composition comprising a drug-polymer matrix
EP0297866A3 (en) Therapeutic agents
ES2009347A6 (es) Procedimiento para la preparacion de una composicion farmaceutica.
ATE163133T1 (de) Pharmazeutische zusammensetzung mit ortspezifischen verabreichung
ES2049617A1 (es) Procedimiento de preparacion de una composicion farmaceutica.
KR970058720A (ko) 향균 및 항진균 활성을 갖는 펩타이드
DE3707369A1 (de) Biologisch abbaubare polymere fuer depotzubereitungen mit kontrollierter wirkstoffabgabe
TH13630EX (th) สารผสมสำหรับการปล่อยสารตัวยาที่ทำให้นานขึ้นและได้รับการควบคุมไว้ และกรรมวิธิสำหรับการเตรียมสารผสมนี้